Spruce Biosciences, Inc. (SPRB)
39.65
-1.82
(-4.39%)
USD |
NASDAQ |
Oct 16, 16:00
40.00
+0.35
(+0.88%)
After-Hours: 20:00
Spruce Biosciences Price : 39.65 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 41.53 | 41.84 | 39.21 | 39.65 | 88434.00 |
| Oct 15, 2026 | 39.00 | 41.88 | 39.00 | 41.47 | 63782.00 |
| Oct 14, 2026 | 40.00 | 41.44 | 38.06 | 38.98 | 113386.0 |
| Oct 13, 2026 | 42.80 | 42.91 | 40.19 | 40.35 | 110799.0 |
| Oct 12, 2026 | 44.09 | 44.94 | 42.55 | 42.87 | 74873.00 |
| Oct 09, 2026 | 44.84 | 45.04 | 42.80 | 44.05 | 83765.00 |
| Oct 08, 2026 | 43.50 | 45.64 | 43.34 | 45.54 | 50815.00 |
| Oct 07, 2026 | 42.56 | 45.40 | 42.37 | 44.40 | 59701.00 |
| Oct 06, 2026 | 45.60 | 46.72 | 42.50 | 42.78 | 101894.0 |
| Oct 05, 2026 | 45.51 | 46.80 | 43.83 | 45.42 | 65087.00 |
| Oct 02, 2026 | 46.58 | 47.72 | 44.12 | 45.71 | 77239.00 |
| Oct 01, 2026 | 48.15 | 49.20 | 44.47 | 44.77 | 79630.00 |
| Sep 30, 2026 | 47.78 | 49.95 | 47.76 | 48.58 | 61255.00 |
| Sep 29, 2026 | 47.55 | 48.00 | 46.55 | 47.27 | 84208.00 |
| Sep 28, 2026 | 48.28 | 48.99 | 47.01 | 47.51 | 42365.00 |
| Sep 25, 2026 | 49.22 | 49.31 | 47.54 | 48.72 | 37189.00 |
| Sep 24, 2026 | 49.01 | 49.50 | 47.58 | 49.02 | 85779.00 |
| Sep 23, 2026 | 50.50 | 50.74 | 45.01 | 49.42 | 174771.0 |
| Sep 22, 2026 | 54.05 | 54.98 | 49.23 | 49.99 | 140921.0 |
| Sep 21, 2026 | 53.84 | 55.06 | 53.07 | 53.70 | 97023.00 |
| Sep 18, 2026 | 53.04 | 53.86 | 51.80 | 53.05 | 99661.00 |
| Sep 17, 2026 | 56.22 | 57.10 | 53.28 | 53.86 | 135266.0 |
| Sep 16, 2026 | 55.01 | 56.27 | 53.26 | 54.16 | 100404.0 |
| Sep 15, 2026 | 55.99 | 56.36 | 54.51 | 55.16 | 110112.0 |
| Sep 14, 2026 | 53.28 | 57.55 | 52.66 | 56.85 | 102622.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.12 |
| Alnylam Pharmaceuticals, Inc. | 231.83 |
| Anika Therapeutics, Inc. | 19.98 |
| Savara, Inc. | 4.45 |
| Vericel Corp. | 40.13 |
Price Related Metrics
| Price to Book Value | 1.304 |
| Earnings Yield | -103.1% |
| Market Cap | 109.15M |